G

Galmed Pharmaceuticals Ltd
D

GLMD

1.30000
USD
0.05
(4.00%)
مفتوح الان
حجم التداول
15,457
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
2,935,444
أصول ذات صلة
A
ALKS
-0.125
(-0.39%)
31.660 USD
A
ARDX
-0.32500
(-7.88%)
3.80000 USD
C
CRIS
0.07000
(2.86%)
2.52000 USD
I
IMAB
0.00150
(0.16%)
0.93000 USD
L
LXRX
0.02550
(3.73%)
0.71000 USD
R
RGNX
-0.370
(-3.56%)
10.020 USD
S
SRRK
-0.340
(-1.03%)
32.650 USD
V
VYGR
-0.10000
(-2.75%)
3.54000 USD
المزيد
الأخبار المقالات

العنوان: Galmed Pharmaceuticals Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.